Skip to main content
. 2020 Feb 13;21(4):1247. doi: 10.3390/ijms21041247
GD Gaucher disease
PG polyclonal gammopathy
MG monoclonal gammopathy
MGUS monoclonal gammopathy of unknown significance
MM multiple myeloma
NHL non-Hodgkin lymphoma
FGDR French Gaucher disease registry
SD standard derivation
IQR interquartile range
HR hazard ratio
CI confident interval
ERT enzyme replacement therapy
SRT substrate reduction therapy